Select the drug indication to add to your list


Bone disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Abaloparatide 2000mcg/mL; soln for SC inj.

Select therapeutic use:

Indications for TYMLOS:

Postmenopausal women with osteoporosis at high risk for fracture.

Limitations Of use:

Cumulative use >2yrs not recommended.


80mcg SC once daily into periumbilical region of abdomen; rotate inj sites. Give supplemental calcium and vitamin D if dietary intake inadequate.


Not recommended.

Boxed Warning:

Risk of osteosarcoma.


Increased baseline risk for osteosarcoma (eg, Paget's disease of bone, unexplained increased alkaline phosphatase, open epiphyses, bone metastases or skeletal malignancies, hereditary disorders predisposing to osteosarcoma, prior external beam or skeletal implant radiation therapy), pre-existing hypercalcemia or underlying hypercalcemic disorder (eg, primary hyperparathyroidism): not recommended. Urolithiasis. Hypercalciuria. Severe renal impairment: monitor. Pregnancy, nursing mothers: not indicated.

Pharmacological Class:

Hormone (human parathyroid hormone related peptide analog).

Adverse Reactions:

Hypercalciuria, dizziness, nausea, headache, palpitations, fatigue, upper abdominal pain, vertigo; orthostatic hypotension, hypercalcemia, urolithiasis, inj site reactions.

Generic Availability:


How Supplied:

Prefilled pen (1.56mL)—1

TYMLOS 1.56ml of 80mcg/dose pens (Qty:1)

appx. price $1830.00